Coronavirus transmission methods lead 2020 cornea coverage
Click Here to Manage Email Alerts
The risk of COVID-19 spreading through tears led Healio/OSN’s coverage on cornea and external diseases in 2020.
Read more of the top-performing articles dealing with cornea issues below.
Coronavirus shows low risk for being spread through tears
SARS-CoV-2 is known to be transmitted via droplets, but infected patients are unlikely to spread the virus through tears, according to a study. Read more.
FDA approves drop for itchy eyes due to allergies
The FDA has approved an over-the-counter preservative-free eye drop for itchy eyes due to certain eye allergies, according to a Bausch Health press release. Read more.
VIDEO: Telehealth a huge challenge with tremendous upside
Marian Macsai, MD, a cornea specialist at NorthShore University HealthSystem in Chicago, discusses the challenges of implementing telehealth but also outlines reasons why she thinks the switch to more telehealth may be the best thing to emerge from the COVID-19 pandemic for physicians. Watch more.
FDA approves Eysuvis for short-term dry eye disease treatment
The FDA has approved Eysuvis for the short-term treatment of dry eye disease signs and symptoms, according to a press release from Kala Pharmaceuticals. Read more.
Woman presents with worsening blurry vision and glare
A 53-year-old woman was referred by her general ophthalmologist for cornea evaluation due to glare and blurry vision that started in her 30s and progressively worsened. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts